People battling alcohol use disorder and obesity may be fighting a craving that starts in their blood sugar, not just their willpower.
Story Snapshot
- A new preliminary study found glucose and insulin resistance levels tracked with alcohol cravings in people with both alcohol use disorder and obesity.
- The link only showed up in that specific group, not in healthy people with obesity or in people with alcohol use disorder alone.
- Cravings spiked after stress and after exposure to alcohol-related cues, two known relapse triggers.
- Researchers call the findings early and hypothesis-generating, meant to guide future relapse-risk research, not a finished diagnostic tool.
What The New Research Actually Found
Scientists publishing in Alcoholism: Clinical and Experimental Research measured glucose, insulin, and insulin resistance in people with alcohol use disorder and obesity together, compared against healthy people with obesity and other control groups. The group with both conditions showed higher glucose levels than healthy controls. That single number opened the door to a much bigger question: does blood sugar chemistry help explain why some people crave alcohol harder than others.
The real finding wasn’t just higher glucose on its own. Researchers found interactions between group status and obesity status affecting insulin and a marker called HOMA, which estimates insulin resistance. In plain terms, the combination of alcohol use disorder and obesity changed how the body handled insulin compared to obesity alone. That combination, not either condition by itself, is where the signal lived.
Why Stress And Cues Matter So Much
Here’s the part that should grab anyone who has tried to quit drinking: glucose and HOMA levels tracked with craving intensity only after participants faced stress or alcohol-related cues, and only in the group with both alcohol use disorder and obesity. Cravings didn’t just appear randomly. They rose alongside metabolic markers specifically when the brain was pushed by stress or temptation, the two triggers addiction doctors already know can derail recovery.
This fits a pattern researchers have studied for years. Stress hormones already reshape how the body manages sugar. Chronic stress can disrupt glucose metabolism and worsen insulin resistance, especially in people carrying extra weight. Separate research has shown that higher baseline glucose predicts more heavy-drinking days during treatment, even after controlling for weight. Blood sugar and drinking behavior have been dancing together in the data for over a decade. This new study adds a sharper lens on exactly who that dance affects most.
What This Does Not Prove Yet
The study’s own authors call these results preliminary and hypothesis-generating, meant to support further testing rather than settle the question. That matters because the broader research on alcohol and insulin is messy. Moderate drinking has been linked in some studies to lower insulin resistance and better insulin sensitivity over time. A large meta-analysis of intervention studies found alcohol didn’t meaningfully change insulin sensitivity or fasting glucose at all, though it did lower certain blood sugar markers. Chronic heavy drinking, by contrast, is well documented to damage glucose tolerance and insulin function over the long run.
None of that contradicts the new findings. It explains why researchers are being careful. Blood sugar’s relationship with alcohol clearly depends on how much someone drinks, how long they’ve been drinking, and whether obesity is part of the picture. This study zeroed in on a narrow, high-risk group facing both alcohol use disorder and obesity together, which is exactly where the signal showed up strongest.
Why This Could Change How Relapse Risk Gets Measured
Addiction medicine has long searched for a reliable biological marker that predicts who is about to relapse, rather than relying only on self-reported cravings. Existing biomarkers already track things like recent alcohol consumption, but few predict future risk with confidence. If glucose and insulin resistance hold up in larger trials, they could give doctors a blood test clue, something concrete to pair with counseling and relapse-prevention plans for patients carrying both conditions.
This research also strengthens the case for studying GLP-1 class drugs, already known for treating diabetes and obesity, as potential tools against alcohol cravings. Yale researchers involved in this work have noted it supports continued investigation of that drug class for alcohol use disorder treatment. For the roughly one in eight American adults who struggle with problem drinking, a treatment built around actual body chemistry, not just talk therapy, would mark real progress grounded in common-sense medicine rather than guesswork.
Sources:
mindbodygreen.com, onlinelibrary.wiley.com, pmc.ncbi.nlm.nih.gov, sciencedirect.com, diabetesjournals.org
